Healthcare -
Biotechnology - NASDAQ - US
$ 55.26
9.27 %
$ 4.36 B
Market Cap
-11.68
P/E
PTCT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PTCT - PTC Therapeutics, Inc.
646 M
LAST VALUE
456.44%
2 YEAR CAGR
37.49%
5 YEAR CAGR
13.18%
10 YEAR CAGR